Feng X, Ren B, Xie W, Huang Z, Liu J, Guan R, Duan M, Xu J
Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Acta Anaesthesiol Scand. 2006 Oct;50(9):1081-8. doi: 10.1111/j.1399-6576.2006.01113.x.
Acute lung injury (ALI) is a progressive syndrome associated with significant mortality in sepsis patients. Neutrophils are key cells in the inflammatory response that characterizes ALI. This study was designed to explore the effects of hydroxyethyl starch (HES) 130/0.4 (a novel plasma substitute) on pulmonary neutrophil recruitment and associated ALI in a rat sepsis model induced by cecal ligation and puncture (CLP).
Animals were randomly assigned to six groups [saline control; CLP and saline; CLP and HES (7.5, 15 and 30 ml/kg); and HES control], subjected to CLP and infused with or without HES 130/0.4 4 h after CLP. Six hours later, the pulmonary capillary permeability (PCP), myeloperoxidase (MPO) activity, lung histological changes, tumor necrosis factor-alpha, interleukin-1beta and cytokine-induced neutrophil chemoattractant levels, P-selectin mRNA expression and nuclear factor-kappa B (NF-kappaB) activation were measured.
Resuscitation with HES 130/0.4 significantly attenuated the CLP-induced increase in PCP, MPO activity, cytokine/chemokine levels, mRNA expression of P-selectin and NF-kappaB activation, all of which are involved in the recruitment of neutrophils. Groups receiving the higher doses of HES 130/0.4 (15 and 30 ml/kg) were more adequately resuscitated.
HES 130/0.4 can inhibit CLP-induced neutrophil recruitment and subsequent ALI by attenuating cytokines/chemokines, adhesion molecule-mediated inflammation and NF-kappaB activation.
急性肺损伤(ALI)是一种与脓毒症患者高死亡率相关的进行性综合征。中性粒细胞是ALI特征性炎症反应中的关键细胞。本研究旨在探讨羟乙基淀粉(HES)130/0.4(一种新型血浆代用品)对盲肠结扎穿刺(CLP)诱导的大鼠脓毒症模型中肺中性粒细胞募集及相关ALI的影响。
将动物随机分为六组[生理盐水对照组;CLP加生理盐水组;CLP加HES(7.5、15和30 ml/kg)组;以及HES对照组],进行CLP,并在CLP后4小时输注或不输注HES 130/0.4。6小时后,测量肺毛细血管通透性(PCP)、髓过氧化物酶(MPO)活性、肺组织学变化、肿瘤坏死因子-α、白细胞介素-1β和细胞因子诱导的中性粒细胞趋化因子水平、P-选择素mRNA表达及核因子-κB(NF-κB)激活情况。
用HES 130/0.4进行复苏可显著减轻CLP诱导的PCP升高、MPO活性升高、细胞因子/趋化因子水平升高、P-选择素mRNA表达及NF-κB激活,所有这些均与中性粒细胞募集有关。接受较高剂量HES 130/0.4(15和30 ml/kg)的组复苏更充分。
HES 130/0.4可通过减轻细胞因子/趋化因子、黏附分子介导的炎症及NF-κB激活来抑制CLP诱导的中性粒细胞募集及随后的ALI。